SEC Form 3 · accession 0000899243-15-007225
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Chan
Officer — See Remarks
Period of report
Oct 28, 2015
Accepted (ET)
Oct 28, 2015 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 40,816 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.51 | holding | — | — | — | — | Jun 3, 2025 | Common Stock | 12,244 | — | D |
Explanation of responses
- F1These shares of Common Stock are subject to the Issuer's right of repurchase, which lapses at a rate of 25% on November 17, 2015, and in 36 equal monthly installments thereafter.
- F225% of the shares subject to this option shall vest and become exercisable on June 4, 2016, and the remaining shares subject to this option shall vest and become exercisable in 36 equal monthly installments thereafter.
Remarks
Vice President, Corporate Controller Exhibit List: Exhibit 24.1 - Power of Attorney